Research Paper Volume 16, Issue 6 pp 5163—5183
Novel histone acetylation-related lncRNA signature for predicting prognosis and tumor microenvironment in esophageal carcinoma
Figure 11. Relationships between risk score and therapeutic sensitivity. (A) Bicalutamide. (B) BMS.536924. (C) Parthenolide. (D) PD.0325901. (E) RDEA119. (F) Etoposide. (G) Lenalidomide. (H) Nilotinib. (I) Pazopanib. (J) Temsirolimus.